Related Experiment Videos
[Vaccination in patients with cirrhosis]
Pierre Loulergue1, Odile Launay,
1Université Paris Descartes, Faculté de Médecine, INSERM CIC BT 505, AP-HP, Groupe Hospitalier Cochin-Saint Vincent de Paul, CIC de Vaccinologie Cochin Pasteur, Pôle de Médecine, F-75679, Paris Cedex 14, France.
Abstract:
Patients with cirrhosis are immunocompromised and have an increased risk of infection, with a worse outcome. Some of those infections may be prevented by vaccination. Immunization can reduce the morbidity and mortality associated with cirrhosis. Immunizations against hepatitis A and B viruses, influenza and pneumococcus are recommended by the French Haute Autorité de Santé since 2007. Vaccination against hepatitis A is recommended in non-immunized cirrhotic patients. Vaccination against hepatitis B is recommended in every cirrhotic patient with no serological markers, and post-vaccinal antibodies titer should be checked. Annual influenza immunization can be done in cirrhotic patients, and pneumococcal polysaccharide vaccination should be repeated after 5 years. Few data regarding vaccination coverage are available, but studies suggest that immunization rates are too low in this population.
Related Concept Videos
Cirrhosis II: Pathophysiology
Cirrhosis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatitis
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Vaccinations